Published on GHDx (https://ghdx.healthdata.org)

Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes

General Info

Geography 
Austria (AUT)
Belgium (BEL)
Bulgaria (BGR)
Czechia (CZE)
Estonia (EST)
France (FRA)
Germany (DEU)
Hungary (HUN)
Italy (ITA)
Latvia (LVA)
Netherlands (NLD)
Poland (POL)
Portugal (PRT)
Romania (ROU)
Russian Federation (RUS)
Slovakia (SVK)
Spain (ESP)
Ukraine (UKR)
United Kingdom (GBR)
View all
Time period covered 
January, 2004 - December, 2009
Data type
Scientific literature
Keywords 
Cardiovascular and circulatory diseases, Blood pressure

Citation

Authors 
Haller H, Ito S, Izzo JL Jr, Januszewicz A, Katayama S, Menne J, Mimran A, Rabelink TJ, Ritz E, Ruilope LM, Rump LC, Viberti G, ROADMAP Trial Investigators
Journal 
N Engl J Med
Pages 
907-17
Publication year 
2011
Suggested citation 
Haller H, Ito S, Izzo JL Jr, Januszewicz A, Katayama S, Menne J, Mimran A, Rabelink TJ, Ritz E, Ruilope LM, Rump LC, Viberti G, ROADMAP Trial Investigators. Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. N Engl J Med. 2011; 364(10): 907-17.
Source URL: https://ghdx.healthdata.org/record/olmesartan-delay-or-prevention-microalbuminuria-type-2-diabetes